Home
LXEH
LXEH News

Latest Lixiang Education Holding Co. Ltd. (LXEH) News on October 5, 2024

Lixiang Education Holding First Half 2024 Earnings: CN¥0.73 loss per share (vs CN¥1.21 loss in 1H 2023)

Simply Wall St.

7 days ago

Lixiang Education Holding First Half 2024 Earnings: CN¥0.73 loss per share (vs CN¥1.21 loss in 1H 2023)

GlobeNewswire

22 days ago

Lixiang Education Announces Plan to Implement ADS Ratio Change

MT Newswires

a month ago

Lixiang Education Names Zhifu Yang CFO

GlobeNewswire

a month ago

Lixiang Education Announces Change of Chief Financial Officer

GlobeNewswire

a month ago

Lixiang Education Received Notice of Failure to Satisfy Continued Listing Rule

GlobeNewswire

5 months ago

Lixiang Education Received Notice of Failure to Satisfy Continued Listing Rule

Tortoise Announces 2023 Closed-End Fund Tax Characterization of Distributions and Release of Combined Annual Report

ACCESSWIRE

8 months ago

Tortoise Announces 2023 Closed-End Fund Tax Characterization of Distributions and Release of Combined Annual Report

Territorial Bancorp Inc. Announces Fourth Quarter 2023 Results

GlobeNewswire

8 months ago

Territorial Bancorp Inc. Announces Fourth Quarter 2023 Results

POET Technologies Announces Closing of C$6.2 Million Non-Brokered Private Placement of Units and Reports Preliminary Unaudited Fiscal Fourth Quarter and Fiscal Year 2024 Results

GlobeNewswire

8 months ago

POET Technologies Announces Closing of C$6.2 Million Non-Brokered Private Placement of Units and Reports Preliminary Unaudited Fiscal Fourth Quarter and Fiscal Year 2024 Results

Lixiang Education Regains Compliance with Nasdaq Minimum Bid Price Requirement

PR Newswire

8 months ago

Lixiang Education Regains Compliance with Nasdaq Minimum Bid Price Requirement

Incannex Commences Dosing in Phase 2 Clinical Trial Assessing IHL-675A in Patients with Rheumatoid Arthritis

GlobeNewswire

8 months ago

Incannex Commences Dosing in Phase 2 Clinical Trial Assessing IHL-675A in Patients with Rheumatoid Arthritis

Cardio Diagnostics Holdings, Inc. Accelerates Cardiac Care Innovation with Appointment of Dr. Vimal Ramjee as Strategic Advisor

Business Wire

8 months ago

Cardio Diagnostics Holdings, Inc. Accelerates Cardiac Care Innovation with Appointment of Dr. Vimal Ramjee as Strategic Advisor

Sypris Solutions (NASDAQ:SYPR) Is Looking To Continue Growing Its Returns On Capital

Simply Wall St.

8 months ago

Sypris Solutions (NASDAQ:SYPR) Is Looking To Continue Growing Its Returns On Capital

Bowen Acquisition Corp Announces Entering into Merger Agreement with Shenzhen Qianzhi BioTech Company

GlobeNewswire

9 months ago

Bowen Acquisition Corp Announces Entering into Merger Agreement with Shenzhen Qianzhi BioTech Company

Incannex Completes Dosing and Therapy in Phase 2 “PsiGAD” Clinical Trial Assessing Psilocybin-assisted Psychotherapy for Generalized Anxiety Disorder; Data Analysis Commences

GlobeNewswire

9 months ago

Incannex Completes Dosing and Therapy in Phase 2 “PsiGAD” Clinical Trial Assessing Psilocybin-assisted Psychotherapy for Generalized Anxiety Disorder; Data Analysis Commences

Casa Systems Named “Global IoT Innovation Vendor of the Year” in 8ᵗʰ Annual IoT Breakthrough Awards Program

GlobeNewswire

9 months ago

Casa Systems Named “Global IoT Innovation Vendor of the Year” in 8ᵗʰ Annual IoT Breakthrough Awards Program

Rapid Micro Biosystems Announces the Upcoming Availability of Rapid Sterility Application for the Growth Direct® System

GlobeNewswire

9 months ago

Rapid Micro Biosystems Announces the Upcoming Availability of Rapid Sterility Application for the Growth Direct® System

Knightscope Receives New Orders from City Hall and Growing Reseller

Business Wire

9 months ago

Knightscope Receives New Orders from City Hall and Growing Reseller

Cardio Diagnostics Holdings, Inc. Announces the Grant of a Patent in India

Business Wire

9 months ago

Cardio Diagnostics Holdings, Inc. Announces the Grant of a Patent in India

YS Biopharma Announces Changes to its Board Committees

PR Newswire

9 months ago

YS Biopharma Announces Changes to its Board Committees

Calidi Biotherapeutics Announces the Appointment of Three New Members to its Scientific and Medical Advisory Board

Business Wire

9 months ago

Calidi Biotherapeutics Announces the Appointment of Three New Members to its Scientific and Medical Advisory Board

Lichen China Limited's (NASDAQ:LICN) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?

Simply Wall St.

9 months ago

Lichen China Limited's (NASDAQ:LICN) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?

Immunic Highlights 2023 Accomplishments and Upcoming Milestones

PR Newswire

9 months ago

Immunic Highlights 2023 Accomplishments and Upcoming Milestones

Budget Bets: Top 3 Penny Stocks with Potential for Explosive Growth

InvestorPlace

9 months ago

Budget Bets: Top 3 Penny Stocks with Potential for Explosive Growth

$Apollomics Completes Enrollment in Phase 3 Bridging Study of Uproleselan in Chinese Patients with Relapsed/Refractory Acute Myeloid Leukemia$

GlobeNewswire

9 months ago

Apollomics Completes Enrollment in Phase 3 Bridging Study of Uproleselan in Chinese Patients with Relapsed/Refractory Acute Myeloid Leukemia

NKGen Biotech, Inc. Announces Dosing of First Patient in its Phase 1/2a Trial with Autologous NK Cell Product, SNK01, for the Treatment of Moderate Alzheimer’s Disease

GlobeNewswire

9 months ago

NKGen Biotech, Inc. Announces Dosing of First Patient in its Phase 1/2a Trial with Autologous NK Cell Product, SNK01, for the Treatment of Moderate Alzheimer’s Disease

Viveon Health Acquisition Corp. Receives Commencement of Delisting Notice From the NYSE

GlobeNewswire

9 months ago

Viveon Health Acquisition Corp. Receives Commencement of Delisting Notice From the NYSE

High Tide Opens Second Canna Cabana in Kanata, Ontario

PR Newswire

9 months ago

High Tide Opens Second Canna Cabana in Kanata, Ontario

Enlivex Announces Completion of Enrollment of Its Phase II Trial Evaluating Allocetra In Patients With Sepsis

GlobeNewswire

10 months ago

Enlivex Announces Completion of Enrollment of Its Phase II Trial Evaluating Allocetra In Patients With Sepsis

Brightcove Appoints New CMO and CRO, Creates COO Position

Business Wire

10 months ago

Brightcove Appoints New CMO and CRO, Creates COO Position

Lixiang Education Announces Plan to Implement ADS Ratio Change

PR Newswire

10 months ago

Lixiang Education Announces Plan to Implement ADS Ratio Change

DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

10 months ago

DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Sandy Spring Bancorp (SASR) Stock Jumps 9.3%: Will It Continue to Soar?

Zacks

10 months ago

Sandy Spring Bancorp (SASR) Stock Jumps 9.3%: Will It Continue to Soar?

LifeVantage Corporation to Participate in Water Tower Fireside Chat Series

GlobeNewswire

10 months ago

LifeVantage Corporation to Participate in Water Tower Fireside Chat Series

OFS Credit Company Announces Financial Results for the Fourth Fiscal Quarter 2023

Business Wire

10 months ago

OFS Credit Company Announces Financial Results for the Fourth Fiscal Quarter 2023

UPDATE -- Babcock develops cutting-edge communications and control technology in partnership with Arqit

GlobeNewswire

10 months ago

UPDATE -- Babcock develops cutting-edge communications and control technology in partnership with Arqit

Babcock develops cutting-edge communications and control technology in partnership with Arqit

GlobeNewswire

10 months ago

Babcock develops cutting-edge communications and control technology in partnership with Arqit

Hongli Group Inc. (NASDAQ:HLP) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?

Simply Wall St.

10 months ago

Hongli Group Inc. (NASDAQ:HLP) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?

PR Newswire

10 months ago

Lixiang Education Receives Nasdaq Extension to Regain $1 Bid Price Compliance

BioAtla Presented Phase 2 Clinical Trial Data at the IASLC 2023 North America Conference on Lung Cancer and Virtual KOL Event

GlobeNewswire

10 months ago

BioAtla Presented Phase 2 Clinical Trial Data at the IASLC 2023 North America Conference on Lung Cancer and Virtual KOL Event

Dynagas LNG Partners LP Announces Date for the Release of the Third Quarter 2023 Results, Conference Call and Webcast

GlobeNewswire

10 months ago

Dynagas LNG Partners LP Announces Date for the Release of the Third Quarter 2023 Results, Conference Call and Webcast

i-80 Gold Expands High-Grade Mineralization in the Blackjack Zone at Ruby Hill

CNW Group

10 months ago

i-80 Gold Expands High-Grade Mineralization in the Blackjack Zone at Ruby Hill

Dynagas LNG Partners LP Announces Results of 2023 Annual Meeting of Limited Partners

GlobeNewswire

10 months ago

Dynagas LNG Partners LP Announces Results of 2023 Annual Meeting of Limited Partners

MDV vs. ESS: Which Stock Is the Better Value Option?

Zacks

10 months ago

MDV vs. ESS: Which Stock Is the Better Value Option?

Grown Brilliance Integrates Katapult to Help Qualified Consumers Acquire High-Quality Diamond Jewelry

GlobeNewswire

10 months ago

Grown Brilliance Integrates Katapult to Help Qualified Consumers Acquire High-Quality Diamond Jewelry

Eagle Pharmaceuticals Announces Management Change

GlobeNewswire

10 months ago

Eagle Pharmaceuticals Announces Management Change

OFS Credit Company Declares Monthly All-Cash Common Stock Distributions for Each of the Three Months in the Quarter Ending January 31, 2024

Business Wire

10 months ago

OFS Credit Company Declares Monthly All-Cash Common Stock Distributions for Each of the Three Months in the Quarter Ending January 31, 2024

Associated Press Finance

10 months ago

Citi Trends: Fiscal Q3 Earnings Snapshot

Down -33.75% in 4 Weeks, Here's Why Eagle Pharmaceuticals (EGRX) Looks Ripe for a Turnaround

Zacks

10 months ago

Down -33.75% in 4 Weeks, Here's Why Eagle Pharmaceuticals (EGRX) Looks Ripe for a Turnaround

FiscalNote Announces Retention of Financial Advisor by the Special Committee of the Board of Directors

Business Wire

a year ago

FiscalNote Announces Retention of Financial Advisor by the Special Committee of the Board of Directors

IN8bio’s INB-200 Demonstrates Extended Progression-Free Survival in Patients with Newly Diagnosed Glioblastoma

GlobeNewswire

a year ago

IN8bio’s INB-200 Demonstrates Extended Progression-Free Survival in Patients with Newly Diagnosed Glioblastoma

OFS Credit Company Provides October 2023 Net Asset Value Update

Business Wire

a year ago

OFS Credit Company Provides October 2023 Net Asset Value Update

Business Wire

a year ago

Cyclo Therapeutics Reports Third Quarter 2023 Financial Results

Business Wire

a year ago

Owlet to Participate in BTIG’s Digital Health Forum

FiscalNote Announces Third Quarter 2023 Financial Results and Reaches Adjusted EBITDA Profitability

Business Wire

a year ago

FiscalNote Announces Third Quarter 2023 Financial Results and Reaches Adjusted EBITDA Profitability

The Central and Eastern Europe Fund, Inc., The European Equity Fund, Inc., and The New Germany Fund, Inc. Announce Appointment of New Chairman of the Board

Business Wire

a year ago

The Central and Eastern Europe Fund, Inc., The European Equity Fund, Inc., and The New Germany Fund, Inc. Announce Appointment of New Chairman of the Board

San Antonio, Texas Clearday (CLRD-OTCQX) is proud to honor our US Veterans through the Company’s Clearday Club in San Antonio, Texas.

GlobeNewswire

a year ago

San Antonio, Texas Clearday (CLRD-OTCQX) is proud to honor our US Veterans through the Company’s Clearday Club in San Antonio, Texas.

Business Wire

a year ago

Owlet Announces Third Quarter 2023 Financial Results

FiscalNote and True Digital Group Announce Partnership Using Risk Connector to Provide Banks with Third- and Fourth-Party Vendor Identification and Risk Monitoring

Business Wire

a year ago

FiscalNote and True Digital Group Announce Partnership Using Risk Connector to Provide Banks with Third- and Fourth-Party Vendor Identification and Risk Monitoring

FitLife Brands Announces Third Quarter 2023 Results

GlobeNewswire

a year ago

FitLife Brands Announces Third Quarter 2023 Results

Declining Stock and Solid Fundamentals: Is The Market Wrong About Eton Pharmaceuticals, Inc. (NASDAQ:ETON)?

Simply Wall St.

a year ago

Declining Stock and Solid Fundamentals: Is The Market Wrong About Eton Pharmaceuticals, Inc. (NASDAQ:ETON)?

IN8bio to Present Data Highlighting Potential of INB-200 and INB-400 to Treat Patients with Newly Diagnosed Glioblastoma Multiforme at Society for Neuro-Oncology 28th Annual Meeting

GlobeNewswire

a year ago

IN8bio to Present Data Highlighting Potential of INB-200 and INB-400 to Treat Patients with Newly Diagnosed Glioblastoma Multiforme at Society for Neuro-Oncology 28th Annual Meeting

Thomson Reuters StreetEvents

a year ago

Q3 2023 Ocugen Inc Earnings Call

Business Wire

a year ago

Owlet Achieves De Novo FDA-Clearance For Dream Sock® – The First and Only Over-the-Counter, Medical Grade Pulse Oximeter Cleared for Infants

PR Newswire

a year ago

Lixiang Education Announces Receipt of Nasdaq Staff Determination Letter and Intent to Request Hearing

ProQR Announces Third Quarter 2023 Operating and Financial Results

GlobeNewswire

a year ago

ProQR Announces Third Quarter 2023 Operating and Financial Results

Redwire Corporation Reports Third Quarter 2023 Financial Results

Business Wire

a year ago

Redwire Corporation Reports Third Quarter 2023 Financial Results

Territorial Bancorp (NASDAQ:TBNK) Has Announced That Its Dividend Will Be Reduced To $0.05

Simply Wall St.

a year ago

Territorial Bancorp (NASDAQ:TBNK) Has Announced That Its Dividend Will Be Reduced To $0.05

Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2023 Financial Results

GlobeNewswire

a year ago

Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2023 Financial Results

Billionaire Marc Lasry’s Top 10 Stock Picks

Insider Monkey

a year ago

Billionaire Marc Lasry’s Top 10 Stock Picks

Protalix BioTherapeutics to Announce Third Quarter 2023 Financial and Business Results on November 6, 2023

PR Newswire

a year ago

Protalix BioTherapeutics to Announce Third Quarter 2023 Financial and Business Results on November 6, 2023

Share on Social Networks: